AVM
Arch Venture Management Portfolio holdings
AUM
$299M
This Quarter Return
+0.33%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$80.3M
AUM Growth
+$80.3M
(-51%)
Cap. Flow
-$82.8M
Cap. Flow
% of AUM
-103.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
2
Increased
–
Reduced
–
Closed
1
Top Buys
| 1 |
Q32 Bio
QTTB
|
$5.46M |
| 2 |
CERo Therapeutics
CERO
|
$4.43M |
Top Sells
| 1 |
Revolution Medicines
RVMD
|
$92.7M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1
DELISTED
Verve Therapeutics
VERV
| $26.7M | 33.23% |
2,008,809
| – | – |
|
2
Erasca
ERAS
$454M
| $22.8M | 28.37% |
11,055,554
| – | – |
|
3
Gossamer Bio
GOSS
$589M
| $9.51M | 11.84% |
8,055,916
| – | – |
|
4
Denali Therapeutics
DNLI
$2.26B
| $7.82M | 9.75% |
381,249
| – | – |
|
|
5
Q32 Bio
QTTB
$20.9M
| $5.46M | 6.8% |
+320,482
| New | +$5.46M |
|
|
6
CERo Therapeutics
CERO
$8.92M
| $4.43M | 5.52% |
+1,444,296
| New | +$4.43M |
|
|
OMIC
7
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $1.95M | 2.43% |
3,798,926
| – | – |
|
|
UBX
8
DELISTED
Unity Biotechnology
UBX
| $1.65M | 2.05% |
1,004,817
| – | – |
|
|
9
Revolution Medicines
RVMD
$7.39B
| – | – |
-3,233,490
| Closed | -$92.7M |
|